Form 4: USANA Health Sciences Director J Scott Nixon Acquires Restricted Stock Units

J Scott Nixon, a director at USANA Health Sciences, acquired 2,697 restricted stock units on May 2, 2024, according to a Form 4 filing with the SEC.

Summary

• On May 2, 2024, J Scott Nixon, a director of USANA Health Sciences Inc., acquired 2,697 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of USNA common stock each.
• The units vest in four equal installments of 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
• Following the transaction, Nixon directly owns 2,697 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock unit acquisition, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of restricted stock units by a director can be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates